ACLX-6.90%8.3%
BBOT-9.10%8.3%
BMY+19.41%8.3%
CMPX-18.95%8.3%
GMAB+36.23%8.3%
JAZZ+119.51%8.3%
KURA+89.94%8.3%
LEGN-31.05%8.3%
NRIX+94.87%8.3%
NUVL+50.88%8.3%
RVMD+396.44%8.3%
ZYME+98.17%8.3%
As of Jul 10, 2026, 7:14 AM ET
Biotech '26: Scalable Oncology Drugs Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Bristol-Myers Squibb CompanyBMY | 8.3% | -0.31% | 0.70% | 0.06% | 3.82% | 7.42% | -7.10% | -1.73% | 19.41% | $118.32B |
Revolution Medicines, Inc.RVMD | 8.3% | 0.37% | 0.72% | -0.77% | 1.93% | 139.96% | 87.35% | 452.40% | 396.44% | $40.63B |
Genmab A/SGMAB | 8.3% | -1.68% | 0.81% | 14.45% | 7.74% | -3.31% | 1.15% | 58.24% | 36.23% | $18.28B |
Jazz Pharmaceuticals plcJAZZ | 8.3% | 0.90% | -0.54% | 3.87% | 3.96% | 45.24% | 29.94% | 95.28% | 119.51% | $15.51B |
Nuvalent, Inc.NUVL | 8.3% | -0.29% | 0.02% | 0.26% | 0.19% | 23.10% | 21.46% | 75.75% | 50.88% | $9.11B |
Legend Biotech CorporationLEGN | 8.3% | 1.81% | -1.76% | -6.84% | -8.40% | 25.94% | 44.11% | -17.63% | -31.05% | $5.06B |
Arcellx, Inc.ACLX | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | -1.67% | 0.00% | -4.64% | -6.90% | $3.75B |
Nurix Therapeutics, Inc.NRIX | 8.3% | -3.81% | 1.56% | 3.52% | 3.26% | 30.15% | 54.60% | 116.96% | 94.87% | $2.14B |
Zymeworks Inc.ZYME | 8.3% | -5.25% | 1.58% | 12.32% | 5.25% | 2.81% | 16.23% | 127.10% | 98.17% | $1.99B |
Kura Oncology, Inc.KURA | 8.3% | 0.00% | -0.33% | 10.12% | 12.06% | 16.27% | 38.37% | 85.28% | 89.94% | $1.07B |
BridgeBio Oncology Therapeutics Inc.BBOT | 8.3% | 5.56% | 0.78% | 18.67% | 16.54% | -27.40% | -9.37% | -9.10% | -9.10% | $728.2M |
Compass Therapeutics, Inc.CMPX | 8.3% | -0.43% | -1.28% | 6.94% | 5.96% | -56.98% | -59.12% | 36.69% | -18.95% | $319.4M |
| Theme return | — | -0.26% | 0.19% | 5.22% | 4.03% | 20.08% | 21.33% | 87.81% | 69.12% | — |
| Average | 8.3% | -0.26% | 0.19% | 5.22% | 4.36% | 16.79% | 18.14% | 84.55% | 69.95% | $18.08B |
| Median | 8.3% | -0.14% | 0.36% | 3.70% | 3.89% | 11.85% | 18.85% | 67.00% | 43.56% | $4.41B |
| Std Dev | 0.0% | 2.58% | 1.00% | 7.12% | 5.98% | 45.37% | 35.75% | 121.09% | 109.99% | $32.19B |
| Min | 8.3% | -5.25% | -1.76% | -6.84% | -8.40% | -56.98% | -59.12% | -17.63% | -31.05% | $319.4M |
| Max | 8.3% | 5.56% | 1.58% | 18.67% | 16.54% | 139.96% | 87.35% | 452.40% | 396.44% | $118.32B |
| % Positive Tickers | 33.33% | 58.33% | 75.00% | 83.33% | 66.67% | 66.67% | 66.67% | 66.67% |
About this theme
Biotech '26: Scalable Oncology Drugs tracks 12 publicly listed stocks in this theme: ACLX, BBOT, BMY, CMPX, GMAB, JAZZ, KURA, LEGN, NRIX, NUVL, RVMD, ZYME. See the constituent table for details.